radiopharmaceutical theranostics cdmo market
Radiopharmaceutical Theranostics CDMO Industry to Reach USD 5.37 Billion by 2034 as Radioligand Therapy and Nuclear Medicine Outsourcing Expand According to a new report published by OG Analysis, the Radiopharmaceutical Theranostics CDMO Market is valued at USD 1.55 billion in 2026 and is projected to reach USD 5.37 billion by 2034, expanding at a CAGR of 16.8%. Demand is being supported by...
0 Σχόλια 0 Μοιράστηκε 13 Views 0 Προεπισκόπηση